ClinicalTrials.Veeva

Menu

Video-Intervention to Inspire Treatment Adherence for Life for Adolescents (VS4A)

Baylor College of Medicine logo

Baylor College of Medicine

Status

Enrolling

Conditions

HIV/AIDS

Treatments

Behavioral: Video-based ART adherence counseling
Behavioral: Standard of Care (SOC)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07064785
H-53963
5UG1MD019436-02 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This a two-arm randomized controlled trial whose objective is to explore the impact of VITAL Start for Adolescents (VS4A), a video-based antiretroviral treatment (ART) adherence intervention, on a range of implementation and effectiveness outcomes. The study will be conducted in health facilities which provide HIV care to teens/adolescents in the Machinga and Balaka districts of Malawi with approximately 900 teens living with HIV and their treatment supporters (dyads). Dyads will be individually randomized on a 1:1 ratio to receive either the intervention or the standard of care. The VS4A intervention is designed to support Information, Motivation, and Behavioral skills (IMB) around adolescent ART adherence as well as strategies for enhancing treatment supporter social support. The intervention consists of: 1) a two-session video package with associated activities that both the adolescent and their treatment supporter will be asked to watch and participate in; 2) ART refill for the adolescent; 3) and intensive adherence counselling for those with a high viral load. The primary outcomes are adoption of the intervention and adolescent viral load suppression. The overall hypothesis is that VS4A will achieve high adoption and improve adolescent viral suppression.

Full description

Adolescents living with HIV (ALHIV)-an estimated 1.7 million globally-face ongoing challenges with HIV medication adherence, retention, and viral load suppression (VLS). With both high rates of incident infection and some of the lowest VLS rates, ALHIV experience high mortality with approximately 100 deaths per day. Successful interventions to improve retention and VLS among ALHIV in low- and middle-income countries (LMIC) remain limited. Video-based counseling interventions have improved HIV knowledge, disclosure, and treatment adherence in other populations and offer a scalable way to deliver standardized content while reducing health care worker burden. Yet, they remain underused for ALHIV in sub-Saharan Africa.

One of the first video-based interventions integrated into HIV care in Malawi was piloted with preliminary findings showing high satisfaction among patients and providers, as well as improvements in ART knowledge, adherence, and retention. Building on these results, the investigators propose to adapt and evaluate VITAL Start (Video-intervention to Inspire Treatment Adherence for Life) for Adolescents (VS4A), a video-based counseling package tailored for ALHIV.

Through a two-arm randomized controlled trial, the aim is to assess the impact of VS4A on implementation and clinical outcomes. Adolescent-treatment supporters from up to 26 health facilities in Malawi will be randomized to receive either the VS4 intervention or the standard of care (SOC). Implementation outcomes will be compared between the VS4A arm and the standard of care arm. The effectiveness outcome of adolescent viral suppression will be compared between the two arms.

The findings from this trial will provide an intervention that standardizes and improves knowledge and behavior at critical teaching moments through an engaging and culturally sensitive experience and inform scalable strategies to improve adolescent HIV care and advance progress toward long-term viral suppression and well-being for ALHIV.

Enrollment

1,800 estimated patients

Sex

All

Ages

10+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Adolescents

Inclusion Criteria:

  • 10-19 years of age
  • In care at the health facility
  • Aware of their HIV status
  • Provide informed consent (if aged 18+ years) or assent and guardian informed consent (if aged 10-17 years).
  • Exclusion Criteria: if their ability to provide informed consent or assent is impaired

Treatment supporters

Inclusion Criteria:

  • >18 years old
  • named as a treatment supporter of an adolescent study participant
  • willing to provide informed consent for oneself
  • Exclusion Criteria: if their ability to provide informed consent is impaired

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,800 participants in 2 patient groups

Video-Based ART Adherence Counseling
Experimental group
Treatment:
Behavioral: Video-based ART adherence counseling
Standard of Care
Active Comparator group
Treatment:
Behavioral: Standard of Care (SOC)

Trial contacts and locations

32

Loading...

Central trial contact

Saeed Ahmed, MD, MSc; Tapiwa Tembo, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems